US Edition
Published • loading... • Updated
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives $72.29 Consensus PT from Brokerages
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives $72.29 Consensus PT from Brokerages
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) have been given an average rating of “Moderate Buy” by the eighteen ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and sixteen have assigned a […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
